6 results
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
associated with end-stage ... III and class IV symptoms ... Treatments may include ... #Management #Cardiology ... Stages #ACCAHA #Algorithm
Esophageal Crohn's Disease Management Algorithm

Assess for Active Symptoms and for Stricturing/Fistulizing Disease
Stricturing DX:
 • Bx r/o
Management Algorithm ... Assess for Active Symptoms ... Endo • Anti-TNF ... #Management #Algorithm ... #treatment #IBD
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
in SBP > 40 - End-organ ... Decompensated CHF ... , Severe Valve Disease ... #criticalcare #algorithm ... #treatment #management
Leukostasis vs Tumor Lysis Syndrome
Leukostasis:
 • Pathophysiology: Large, immature blasts and high WBC count cause hyperviscosity
Leukostasis: • Pathophysiology ... + lab signs of end ... Lysis Syndrome: • Pathophysiology ... Lysis of tumor cells ... TLS #diagnosis #management
Disseminated Intravascular Coagulation (DIC) Overview

Increased Clotting and Consumption of Clotting Factors

Findings:
 • Bleeding
 • Recent history
protein C and S Pathophysiology ... Fibrinolysis → End ... • Severe Liver Disease ... + Bleeding Treatment ... #management #hematology
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Bilateral signs and/or symptoms ... Pleocytosis > 100 cells ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management